Skip to content
[P]pubcas
🌐 English
EnglishEnglish简体中文Simplified Chinese繁體中文Traditional ChineseEspañolSpanishFrançaisFrenchDeutschGermanPortuguêsPortugueseРусскийRussianالعربيةArabic日本語Japanese한국어KoreanItalianoItalianNederlandsDutchPolskiPolishTürkçeTurkishTiếng ViệtVietnameseไทยThaiBahasa IndonesiaIndonesianBahasa MelayuMalayहिन्दीHindiবাংলাBengaliاردوUrduفارسیPersianעבריתHebrewУкраїнськаUkrainianRomânăRomanianČeštinaCzechSlovenčinaSlovakMagyarHungarianΕλληνικάGreekБългарскиBulgarianSvenskaSwedishDanskDanishNorsk bokmålNorwegian BokmalSuomiFinnishEestiEstonianLatviešuLatvianLietuviųLithuanianSlovenščinaSlovenianHrvatskiCroatianСрпскиSerbianBosanskiBosnianМакедонскиMacedonianShqipAlbanianAzərbaycanAzerbaijaniქართულიGeorgianՀայերենArmenianҚазақшаKazakhOʻzbekchaUzbekКыргызчаKyrgyzТоҷикӣTajikTürkmençeTurkmenМонголMongolianनेपालीNepaliසිංහලSinhalaதமிழ்TamilతెలుగుTeluguमराठीMarathiગુજરાતીGujaratiಕನ್ನಡKannadaമലയാളംMalayalamਪੰਜਾਬੀPunjabiଓଡ଼ିଆOdiaঅসমীয়াAssameseမြန်မာBurmeseខ្មែរKhmerລາວLaoFilipinoFilipinoKiswahiliSwahiliAfrikaansAfrikaansአማርኛAmharicHausaHausaYorùbáYorubaIgboIgboisiZuluZuluisiXhosaXhosaSoomaaliSomaliMalagasyMalagasyKinyarwandaKinyarwandaChiShonaShonaChichewaChichewaپښتوPashtoسنڌيSindhiKurdîKurdish KurmanjiБеларускаяBelarusianÍslenskaIcelandicGaeilgeIrishCymraegWelshMaltiMalteseEuskaraBasqueCatalàCatalanGalegoGalicianLëtzebuergeschLuxembourgishBasa JawaJavaneseBasa SundaSundaneseKreyòl ayisyenHaitian CreoleMāoriMaoriGagana SamoaSamoanLatinaLatinEsperantoEsperanto
Independent chemical reference Compare
Chemical substance record

Ketorolac

74103-06-3C15H13NO3255.273 g/mol

A racemate comprising equimolar amounts of (R)-(+)- and (S)-(−)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(−) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure. — ChEBI

Quick answers Safety references

Quick answers about Ketorolac

Identity · formula · mass

What is Ketorolac, CAS 74103-06-3?

Ketorolac is the substance linked to CAS 74103-06-3 in ChEBI entry CHEBI:6129. The reported formula is C15H13NO3. Confirm the structural identifiers when distinguishing salts, hydrates, isomers or isotopically labelled materials.

Source ↗

What is the molar mass of Ketorolac?

The ChEBI-reported molar mass is 255.273 g/mol for formula C15H13NO3. Its source-reported monoisotopic mass is 255.08954 Da; that uses a specific isotope composition and is a different quantity.

Source ↗

Which PubChem properties are available for Ketorolac?

CID 3826 is connected to this record by an exact InChIKey match. PubChem reports exact mass 255.08954328 Da. Values and source conventions are shown separately in the property tables below.

Source ↗

Identity & molecular properties

Source-linked values
CAS number74103-06-3ChEBI ↗
Chemical formulaC15H13NO3ChEBI ↗
Molar mass255.273 g/molChEBI ↗
Monoisotopic mass255.08954 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:6129ChEBI ↗

PubChem molecular properties

PubChem
Molar mass255.27 g/molPubChem ↗
Exact mass255.08954328 DaPubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
ketorolac
rac-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
OZWKMVRBQXNZKK-UHFFFAOYSA-N
O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)

Names & synonyms

ketorolacoketorolacumrac-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antibacterial agentnon-steroidal anti-inflammatory druganalgesiccardiovascular drugantineoplastic agentcyclooxygenase 2 inhibitorcyclooxygenase 1 inhibitorophthalmology druganti-inflammatory agentvulnerary

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00391737 mol

Uses 255.273 g/mol from ChEBI; basis: the substance and formula represented in this record. No purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 15 atoms
70.58%
O
Oxygen · 3 atoms
18.80%
N
Nitrogen · 1 atom
5.49%
H
Hydrogen · 13 atoms
5.13%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. ↗The Journal of pharmacology and experimental therapeutics · 1999 Mar · PMID 10027870
Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children. ↗Clinical pharmacology and therapeutics · 1999 Apr · PMID 10223774
BE856681 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US4089969 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US4347186 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:6129

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 3826 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.